BIOLARGO, INC. Operating Income Loss

• BIOLARGO, INC. showed a decrease of -243.0% in Operating Income Loss from 2024 to 2025.
• This data is from BIOLARGO, INC.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), BIOLARGO, INC.'s Operating Income Loss has declined by 253.8%.
• Historical annual values: Fiscal year 2025: -$14.86 million | Fiscal year 2024: -$4.33 million | Fiscal year 2023: -$4.58 million | Fiscal year 2022: -$5.39 million | Fiscal year 2021: -$6.78 million | Fiscal year 2020: -$7.58 million | Fiscal year 2019: -$6.70 million | Fiscal year 2018: -$6.41 million | Fiscal year 2017: -$5.90 million | Fiscal year 2016: -$4.93 million | Fiscal year 2015: -$4.18 million | Fiscal year 2014: -$3.39 million | Fiscal year 2013: -$2.62 million | Fiscal year 2012: -$4.72 million | Fiscal year 2011: -$3.16 million | Fiscal year 2010: -$4.20 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026